Year: 1998
Type: letter
Abstract: Patel et al. (4) compared the serum bactericidal titers (SBTs) and the time serum drug concentrations remained above the MICs (T. MIC) of ceftizoxime and cefotaxime against three intermediately penicillin-resistant Streptococcus pneumoniae isolates. MICs were # 1.0 mg/ml, SBTs were. 1:2, and T. MIC exceeded 50 % of dosage intervals. They concluded that ceftizoxime’s longer T. MIC compensates for its lower microbiologic activity, that both agents should pro-duce comparable clinical outcomes in the treatment of infec-tions caused by intermediately penicillin-resistant S. pneu-moniae, and that the two agents can be viewed as being therapeutically similar. While we do not dispute the accuracy of the data, some conclusions are not justified based on the information presented. Furthermore, Patel et al. (4) do not address other clinical and laboratory implications regarding
Authors: Ken B. Waites, Thomas Rivers
Institutions: University of Alabama at Birmingham, UAB Medicine
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2169670150
